I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy but not meeting criteria for overt or preexisting diabetes mellitus, with or without remission after the end of pregnancy.\[[@ref1]\] GDM has drawn scientific attention over the past decades because of its growing incidence and deleterious consequences for mothers and their offsprings.\[[@ref2]\] Insulin resistance is the hallmark of GDM, but the exact mechanism implicated in its pathophysiology remains poorly understood. Historically, placental hormones, especially human placental lactogen, have been considered as primary mediators of insulin resistance during pregnancy leading to GDM.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9]\] However, more recently, an inflammatory cytokine, tumor necrosis factor-alpha (TNF-α), has been implicated in the regulation of maternal metabolism and gestational insulin resistance.\[[@ref10]\] Several studies have investigated the relationship between serum levels of TNF-α and insulin resistance in women with GDM, but reports are inconsistent or even conflicting, especially across different ethnic groups.\[[@ref11][@ref12][@ref13][@ref14][@ref15]\]

There is a paucity of data on the relationship between circulating levels of TNF-α and insulin resistance in women of African ancestry and living in Sub-Saharan Africa with GDM.

Thus, we investigated the association between circulating level of TNF-α and insulin resistance in Nigerian women with GDM.

M[ETHODOLOGY]{.smallcaps} {#sec1-2}
=========================

Two hundred pregnant women with singleton pregnancy at 24--28 weeks' gestation were enrolled in the study, 100 with GDM as diagnosed by the WHO criteria (2-h 75 g oral glucose tolerance test \[OGTT\]: fasting serum glucose \[FSG\] ≥7.0 mmol/L or 2-h postload serum glucose ≥7.8 mmol/L)\[[@ref16]\] and 100 controls (pregnant women with normal gestation). They were all recruited from pregnant women who attended antenatal clinics of Ahmadu Bello University Teaching Hospital Zaria, Sick Bay at Ahmadu Bello University Zaria, and Hajiya Gambo Sawaba General Hospital Zaria, Kaduna State, from May 2014 to June 2015. All were Nigerians of African descent. Written informed consent was obtained from each patient, before recruitment into the study. The study was approved by the Health Research Ethics Committee of Ahmadu Bello University Teaching Hospital, Zaria and Kaduna State Ministry of Health, Kaduna. Pregnant women with multiple gestations, history of pre-GDM, or any preexisting illness were excluded from the study.

Information on maternal age, gestational age, and parity were all obtained from the patients and recorded. Gestational age was based on the report of ultrasound scan.

Height and weight were measured with the patients standing without shoes or heavy outer clothing. Weight was measured using adult weighing scale (ZT-160, UK) and rounded to the nearest kilogram. Height was measured with patients standing on a hard flat surface against a wall using tape rule/stadiometer (ZT-160, UK) and rounded to the nearest centimeter. Body mass index (BMI) was calculated as the ratio of weight in kilogram to square of height in meters and expressed as kg/m^2^. The patients were educated regarding the procedure of OGTT and were instructed to be on their normal diet 3 days before the procedure and then fasted for 10--12 h (overnight) before the OGTT procedure. A fasting blood sample was taken for the measurement of FSG, fasting insulin, and TNF-α. The patients were then given a 75 g dose of glucose (in 300 ml of water) orally over 5--10 min. Blood sample was taken at 2 h postglucose dose for the measurement of 2 h serum glucose.

Biochemical analyses {#sec2-1}
--------------------

Fasting and 2-h postload serum glucose were measured using the glucose oxidase method (LabKit France). Fasting serum insulin (FSI) was measured using human insulin ELISA kit (Perfemed Group Inc. China). Serum TNF-α was measured using human TNF-α ELISA kit (Wkea Med Supplies Corp., China). All blood samples were treated the same throughout the process of blood collection, transport, storage, and assay. All the analyses were done at the Chemical Pathology Laboratory of Ahmadu Bello University Teaching Hospital, Zaria. Insulin resistance was calculated as homeostasis model assessment of insulin resistance (HOMA-IR).\[[@ref17]\]

HOMA-IR = FSI × FSG/22.5.\[[@ref17]\]

FSI in μU/mL and FSG in mmol/L.

Statistical analysis {#sec2-2}
--------------------

Statistical analysis was done using IBM SPSS Statistics version 20.0. Each analyte was examined for outliers and tested for normality of distribution using Kolmogorov--Smirnov test. Data presentation was done using tables and figures. Quantitative variables were summarized using measures of central tendency and dispersion. To compare mean differences between groups, *t*-test was used. Correlations were examined using partial correlation and linear regression analysis. A multiple linear regression analysis was performed to investigate the influence of TNF-α on insulin resistance while adjusting for confounders (age and BMI). All *P* values were two-sided and considered significant if \<0.05.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Clinical and biochemical characteristics of the study patients are presented in [Table 1](#T1){ref-type="table"}. Both the pregnant women with GDM and the controls have similar ages of 25.6 ± 5.4 versus 26.9 ± 5.4 years, respectively (*P* \> 0.05). Gestational age and parity also did not differ significantly between the two study groups (26.5 ± 1.7 vs. 26.7 ± 1.6 weeks, *P* \> 0.05) and (2.3 ± 1.5 vs. 2.6 ± 1.7, *P* \> 0.05), respectively. In comparison with the controls, pregnant women with GDM showed significantly greater pregnancy BMI (25.4 ± 4.0 vs. 23.4 ± 3.7 kg/m^2^, *P* \< 0.05). Fasting insulin was also higher among the pregnant women with GDM than the controls (16.7 ± 2.5 vs. 15.5 ± 2.5 mU/ml, *P* \< 0.05). Insulin resistance as measured by HOMA-IR indicated that the pregnant women with GDM were more insulin resistant than the controls (3.14 ± 0.19 vs. 2.89 ± 0.20, *P* \< 0.05).

###### 

Clinical and biochemical characteristics of the study participants

                                              Mean±SD     *P*         
  ------------------------------------------- ----------- ----------- -------
  Sample size (*n*)                           100         100         
  Age (years)                                 25.6±5.4    26.9±5.4    0.074
  Parity                                      2.3±1.5     2.6±1.7     0.166
  Gestational age (weeks)                     26.5±1.7    26.7±1.6    0.241
  Weight (kg)                                 65.1±15.0   61.1±13.4   0.048
  Height (cm)                                 159±7.5     161±7.0     0.101
  BMI (kg/m^2^)                               25.4±4.0    23.4±3.7    0.000
  Systolic blood pressure (mmHg)              117.2±7.5   118.3±5.5   0.240
  Diastolic blood pressure (mmHg)             78.5±4.8    78.8±4.1    0.635
  Fasting serum glucose (mmol/L)              4.3±0.6     4.3±0.7     0.763
  2-h serum glucose (mmol/L)                  9.0±0.9     6.3±0.8     0.000
  Serum fasting insulin (µU/mL)               16.7±2.6    15.5±2.5    0.000
  Serum tumor necrosis factor-alpha (pg/ml)   2.49±0.30   2.05±0.28   0.000
  HOMA-IR                                     3.14±0.19   2.89±0.20   0.000

SD=Standard deviation, GDM=Gestational diabetes mellitus, HOMA-IR=Homeostasis model assessment of insulin resistance, BMI=Body mass index

The relationship between serum TNF-α level and insulin resistance appeared different between the two study groups, being only significantly associated among the pregnant women with GDM. There was a positive correlation between serum TNF-α level and HOMA-IR among the pregnant women with GDM (*r* = 0.49, *P* \< 0.05) \[[Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}\]. The observed association remained significant after adjusting for age and BMI. Multiple linear regression was used to determine the contributions of TNF-α to HOMA-IR. The adjusted *R*^2^ was 0.23, demonstrating that 23% of the variance in HOMA-IR among the pregnant women with GDM can be attributed to serum levels of TNF-α. TNF-α was found to be significant predictors of HOMA-IR in GDM \[[Table 3](#T3){ref-type="table"}\].

###### 

Correlation of serum tumor necrosis factor-alpha with anthropometric and biochemical factors among the study participants

                                  GDM patients   Controls           
  ------------------------------- -------------- ---------- ------- -------
  Age (years)                     0.25           0.013      0.51    0.000
  BMI (kg/m^2^)                   0.19           0.059      0.83    0.000
  Fasting serum insulin (µU/ml)   0.24           0.020      0.04    0.690
  HOMA-IR                         0.49           0.000      −0.04   0.730

HOMA-IR=Homeostasis model assessment of insulin resistance, BMI=Body mass index, *r*=Correlation coefficient, GDM=Gestational diabetes mellitus

![Correlation serum tumor necrosis factor-alpha levels and homeostasis model assessment of insulin resistance among the pregnant women with gestational diabetes mellitus](AAM-17-168-g001){#F1}

###### 

Multiple regression analysis with log homeostasis model assessment of insulin resistance as a dependent variable among the study participants

  Independent variables   GDM patients (*n*=100) *R*^2^=0.23   Controls (*n*=100) *R*^2^=0.00                          
  ----------------------- ------------------------------------ -------------------------------- ------- ------ ------- ----
  Constant                0.40                                                                          0.44           
  Log TNF-α               0.25                                 0.045                            0.000   0.05   0.049   NS

β=Regression coefficient, SE=Standard error, NS=Not significant, TNF-α=Tumor necrosis factor-alpha, GDM=Gestational diabetes mellitus

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

It was found in this study that there were no significant differences between the pregnant women with GDM and the normal controls in terms of age, weeks of gestation, and parity. It was demonstrated in this study that higher TNF-α levels among the pregnant women with GDM were strongly associated with increased insulin resistance as assessed by HOMA-IR. These associations remained significant even after adjustment for age and BMI. This is in keeping with majority of available studies, showing that higher TNF-α levels in pregnant women are associated with increased insulin resistance and therefore higher risk of developing GDM.\[[@ref13][@ref14][@ref15]\]

By contrast, McLachlan *et al*. did not find a significant correlation between TNF-α and insulin resistance among pregnant women with GDM. Their negative findings might be explained by the limited sample size (19 GDM and 19 control participants) and the relatively older study participants (mean age of 33 years for both the GDM patients and the controls).\[[@ref11]\] Adding to the controversy, Saucedo *et al*., in a study involving 60 pregnant women with GDM and 60 pregnant women with normal glucose tolerance (controls), also found no significant correlation between these parameters.\[[@ref12]\] The discrepancy in this case may be due to the greater BMI of their study participants (mean BMI of 30 kg/m^2^ and 28 kg/m^2^ for the GDM and control groups, respectively). Differences in ethnicity of the study populations, nature of sample (serum or plasma) used, and the type of assay method used in the various studies might also be partially responsible for the discrepancies in the findings between these investigators.

TNF-α promotes serine phosphorylation of insulin receptor substrate-1, thus impairing its association with the insulin receptor.\[[@ref18][@ref19][@ref20]\] Therefore, elevated levels of TNF-α in GDM could attenuate insulin signaling, thus causing the increased insulin resistance observed in GDM. It has also been demonstrated that TNF-α decreases adiponectin gene expression in human adipocytes.\[[@ref20][@ref21]\] Thus, the increase in TNF-α might lead to the lower level of adiponectin which is an insulin-sensitizing hormone, thereby further increasing insulin resistance.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

It is concluded that among pregnant Nigerian women with GDM in this study, higher serum TNF-α level is significantly associated with increased insulin resistance. We recommend that additional investigations that will examine the effects of lifestyle factors on the serum level of TNF-α and its pattern from first to third trimester in relation to the insulin resistance are required within the population, so as to improve the understanding of mechanism underlying the alterations of this cytokine in GDM.
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